Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Jenny Shan, MD, Ph.D
Chief Scientific Officer at Cyagen Biosciences
Speaker

Profile

Jenny holds an MD and a PhD in Cancer Biology from Columbia University. She has supported numerous internally developed and externally licensed biologics programs from discovery through IND and regulatory approval, including blockbuster therapies Eylea, Dupixent, Carvykti, and Rybrevant.

Jenny Currently is the Chief Scientific Officer at Cyagen, where she evaluates innovative technology platforms and preclinical and early clinical biologics assets spanning immunology, oncology, and metabolism.

Agenda Sessions

  • HUGO-Nano: A Human VHH Mouse Platform Engineered with Camelid Features

    , 9:50am